Literature DB >> 20480235

Apocynin activity in spontaneously hypertensive rats (SHR): preliminary studies in vivo.

R Ciarcia1, S Damiano, C Panico, R Scanni, F Fiorito, S Florio, J W Welch.   

Abstract

An elevation in angiotensin II (Ang II) levels is a common occurrence in spontaneously hypertensive rats (SHRs). Infusions of Ang II and a high salt diet increase the activity of NADPH oxidase that stimulates superoxide anion (O(-2)) generation and increases the expression of certain subunits of NADPH oxidase. Apocynin, an NADPH oxidase inhibitor with antihypertensive effects, is able to inhibit the release of superoxide anion by inhibiting NADPH oxidase activity and blocking the migration of p47 phox to the mitochondrial membrane. The aim of our study was to evaluate the antihypertensive effects of apocynin in SHRs and Wistar rats (WKYs) using a micropuncture technique. After microperfusion of both the proximal and distal tubules, we found that SHRs treated with apocynin showed a decrease in the free-flow collection of the proximal tubule (PT), which was not affected in WKYs. Moreover, significant differences were not demonstrated in the distal tubule (DT), probably due a mechanism of compensation that occurs in the loop of Henle. In conclusion, it is possible that the mechanisms of reabsorption in the PT are controlled by the interactions of O(-2) and nitric oxide (NO). These data could suggest a higher activity of NADPH oxidase and increase in reactive oxygen species (ROS) production in the PT during hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20480235     DOI: 10.1007/s11259-010-9377-2

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  9 in total

Review 1.  NADPH oxidase: an update.

Authors:  B M Babior
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

2.  Nephron pO2 and renal oxygen usage in the hypertensive rat kidney.

Authors:  W J Welch; H Baumgärtl; D Lübbers; C S Wilcox
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

3.  Activation of NAD(P)H oxidase by outward movements of H+ ions in renal medullary thick ascending limb of Henle.

Authors:  Ningjun Li; Guo Zhang; Fu-Xian Yi; Ai-Ping Zou; Pin-Lan Li
Journal:  Am J Physiol Renal Physiol       Date:  2005-06-21

4.  Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa.

Authors:  W J Welch; C S Wilcox
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase.

Authors:  Chagriya Kitiyakara; Tina Chabrashvili; Yifan Chen; Jonathan Blau; Alex Karber; Shakil Aslam; William J Welch; Christopher S Wilcox
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

6.  Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II.

Authors:  Dan Wang; Yifan Chen; Tina Chabrashvili; Shakil Aslam; Lillian J Borrego Conde; Jason G Umans; Christopher S Wilcox
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

Review 7.  NADPH oxidase.

Authors:  Bernard M Babior
Journal:  Curr Opin Immunol       Date:  2004-02       Impact factor: 7.486

8.  Renal tubular reabsorption in spontaneously hypertensive rats.

Authors:  W J Arendshorst; W H Beierwaltes
Journal:  Am J Physiol       Date:  1979-07

9.  Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease.

Authors:  David G Harrison; Hua Cai; Ulf Landmesser; Kathy K Griendling
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2003-06       Impact factor: 1.636

  9 in total
  1 in total

1.  Squid Ink Polysaccharides Protect Human Fibroblast Against Oxidative Stress by Regulating NADPH Oxidase and Connexin43.

Authors:  Ying Chen; Huazhong Liu; Hao Huang; Yuetang Ma; Ruihua Wang; Yong Hu; Xiufen Zheng; Chunmei Chen; Hongfeng Tang
Journal:  Front Pharmacol       Date:  2020-01-17       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.